Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership GroupJacqueline Huvane, Lauren Komarow, Carol Hill, et al.
Clinical Pharmacology and Therapeutics|June 10, 2022
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing RegimensLénaïg Tanneau, Mats O Karlsson, Susan L Rosenkranz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 5, 2010
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200Michael F Para, Jeff Schouten, Susan L Rosenkranz, et al.
BMC Infectious Diseases|August 3, 2017
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot studyDmitriy M Martirosov, Monique R Bidell, Manjunath P Pai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trialCharles Flexner, Camlin Tierney, Robert Gross, et al.
The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2020
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical TrialKelly E Dooley, Sachiko Miyahara, Florian von Groote-Bidlingmaier, et al.
Drug and Alcohol Dependence|January 18, 2016
Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individualsRaquel B De Boni, Lu Zheng, Susan L Rosenkranz, et al.
Pharmacogenetics and Genomics|February 28, 2020
Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptivesDavid W Haas, Yoninah S Cramer, Catherine Godfrey, et al.
Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.
Pageof 7